Li H, Qin S, Liu Y, Chen Z, Ren Z, Xiong J, . . . Zou J. (2021). Camrelizumab Combined with FOLFOX4 Regimen as First-Line Therapy for Advanced Hepatocellular Carcinomas: A Sub-Cohort of a Multicenter Phase Ib/II Study. Dove Medical Press.
Chicago Style (17th ed.) CitationLi H, et al. Camrelizumab Combined with FOLFOX4 Regimen as First-Line Therapy for Advanced Hepatocellular Carcinomas: A Sub-Cohort of a Multicenter Phase Ib/II Study. Dove Medical Press, 2021.
MLA (9th ed.) CitationLi H, et al. Camrelizumab Combined with FOLFOX4 Regimen as First-Line Therapy for Advanced Hepatocellular Carcinomas: A Sub-Cohort of a Multicenter Phase Ib/II Study. Dove Medical Press, 2021.
Warning: These citations may not always be 100% accurate.